50 /100
MEDIUM RISK
Score updated May 30, 2026

PCSA — Processa Pharmaceuticals, Inc. Dilution Risk Tracker

Track PCSA dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track PCSA — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
85
📊 Float Risk
15
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
33%
📉 Score Deterioration 40%
• Score rose 30 points recently (worsening)
💰 Capital Raise 35%
• Low cash runway: 3 months remaining
🔄 Reverse Split 15%
• Only 3 months cash — financial pressure
🔔 Track PCSA — Get forecast alerts →

💹 Market Data

Market Cap$7.04M
Shares Outstanding2.75M
Float2.48M
Cash$1.69M
DebtN/A
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↓ 100.0% shares (2025Q4 vs prior)
1 institutional holders · 378 shares
#1 BANK OF AMERICA CORP /DE/ 378 shares

📉 Short Interest

Short Interest116.6K
Days to Cover1.9
% of Float4.7%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2023
xbrl XBRL CONVERTIBLE Mar 31, 2020
4 INSIDER TRANSACTION Apr 17, 2026
4 INSIDER TRANSACTION Apr 17, 2026
4 INSIDER TRANSACTION Apr 17, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track PCSA Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking PCSA — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for PCSA
📊 PCSA FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 PCSA Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.